hAd5 vector-delivered ACE2 decoy therapeutic (ImmunityBio)

N/A

Report date: 2025/01/26 19:01:57

Base Information

Drug NamehAd5 vector-delivered ACE2 decoy therapeutic (ImmunityBio)
Drug Alias NameACE2-IgG1FC fusion protein (ImmunityBio)SARS-CoV-2 Spike Protein Inhibitor (ImmunityBio)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNantcell Inc
China Registration ClassN/A

Develop Information

Active CompaniesNantcell Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A